Discover the power of TARGATT™ technology and find available kits ⟶

Contact Us
Contact Us

Applied StemCell and RoosterBio collaborate to advance scalable iPSC-based bioprocessing

Applied StemCell and RoosterBio collaborate to advance scalable iPSC-based bioprocessing Applied StemCell (ASC) is excited to announce a strategic partnership with RoosterBio focused on developing and commercializing scalable iPSC-based bioprocess solutions for advanced therapy developers. The collaboration will pair our GMP-compatible induced pluripotent stem cell (iPSC) technology with RoosterBio’s engineered media, reagents, and scalable bioprocess […]

Applied StemCell and Syntax Bio collaborate to advance next-generation regenerative medicine

Applied StemCell and Syntax Bio collaborate to advance next-generation regenerative medicine Applied StemCell (ASC) is excited to announce a strategic collaboration with Syntax Bio focused on advancing stem cell research and accelerating the development of future regenerative medicine applications. The collaboration will evaluate our engineered iPSC and hypoimmunogenic cell platforms using Syntax Bio’s proprietary Cellgorithm™ […]

Applied StemCell and Cellipont Bioservices partner to offer a seamless path for iPSC-derived cell therapy development

Applied StemCell and Cellipont Bioservices partner to offer a seamless path for iPSC-derived cell therapy development March 24, 2026 5:00 AM PST Milpitas, CA and The Woodlands, TX — March 24, 2026 – Applied StemCell, Inc. (“ASC”), a genome engineering company with deep expertise in induced pluripotent stem cell (iPSC) technology and Cellipont Bioservices, a cell therapy contract development and manufacturing organization (CDMO), today announced a strategic collaboration designed to streamline […]

Applied StemCell Demonstrates Efficient Knock-In of a 50 kb DNA Construct into Human iPSCs Using TARGATT™ Technology

Applied StemCell demonstrates efficient knock-in of a 50 kb DNA construct into human iPSCs using TARGATT™ technology November 11, 2025 8:00 AM PST Milpitas, CA — Applied StemCell, Inc. (ASC), today announced the successful knock-in of a 50 kilobase (kb) multifunctional DNA insert into human induced pluripotent stem cells (iPSCs) using its proprietary TARGATT™ technology. […]

Welcome to the team, Kaytrina!

Celebrating our growing Business Development team September 17, 2025 11:00 AM PST We’re thrilled to welcome Kaytrina Anchelia as a Director of Business Development. With nearly a decade of experience driving significant business growth at OmniaBio, iVexSol, and Akron Bio, she brings deep commercial expertise in the cell and gene therapy space. Kaytrina will leverage […]

Applied StemCell Appoints Dolores Baksh, Ph.D., as Chief Executive Officer

Applied StemCell Appoints Dolores Baksh, Ph.D., as Chief Executive Officer August 21, 2025 10:00 AM PST Applied StemCell, a genome engineering product and services company, announced today the appointment of Dolores Baksh, Ph.D., as Chief Executive Officer. Company founder and former CEO Ruby Tsai, Ph.D., will continue to guide scientific strategy, innovation, and strategic collaborations […]

Applied StemCell Brand Refresh: Building the biology-based future

Applied StemCell’s Brand Refresh: Building the biology-based future January 30, 2025 12:00 PM PST Drug discovery is a famously challenging endeavor, with a 96% failure rate, a $1B+ price tag to develop a single drug, and a 10+ year timeline from discovery to commercialization. What if we could invert those numbers? Turn a 96% failure […]

Applied StemCell welcomes two seasoned leaders to our team

January 14, 2025 9:00 AM PST Milpitas, California, January 2025 – Applied StemCell, Inc., a proven CRO/CDMO and gene editing technology developer, is pleased to welcome Todd Garland to our Board of Directors and Mike Yurkovich as Vice President of Sales. Todd Garland brings over 30 years of expertise in product management, sales, and commercial […]